Evidence map›Paper›PMID 40613327›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2025

The Impact of Nicotine Reduction on Cigarette Reinforcement Value Within a Marketplace Containing Alternative Nicotine Delivery Products: A Secondary Analysis of a Multi-Site Trial.

Tracy T Smith, Xianghua Luo, Neal L Benowitz, Suzanne M Colby, F Joseph McClernon, Andrew A Strasser, Jennifer W Tidey, Eric C Donny, Dorothy K Hatsukami

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tracy T SmithDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0003-3109-9106
Xianghua LuoMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Neal L BenowitzDepartment of Medicine, School of Medicine, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-2041-8124
Suzanne M ColbyCenter for Alcohol and Addiction Studies, School of Public Health, Brown University, Providence, RI, USA.ORCID 0000-0003-2027-5936
F Joseph McClernonDepartment of Psychiatry and Behavioral Sciences, School of Medicine, Duke University, Durham, NC, USA.
Andrew A StrasserDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jennifer W TideyCenter for Alcohol and Addiction Studies, School of Public Health, Brown University, Providence, RI, USA.
Eric C DonnyDepartment of Translational Neuroscience, School of Medicine, Wake Forest University, Winston-Salem, NC, USA.ORCID 0000-0003-3288-9652
Dorothy K HatsukamiMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-1108-2609

Funding

VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIAU54DA031659 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HATSUKAMI, DOROTHY K · 2011 to 2022
$64.7M
National Cancer Institute Cancer Center Support P30CA077598National Institute of Drug Abuse and the Food and Drug Administration's Center for Tobacco Products U54DA03165National Institutes of Health's National Center for Advancing Translational Sciences UL1TR002494NIDA NIH HHS U54 DA031659U.S. National Institute of Drug Abuse and the Food and Drug Administration's Center for Tobacco Products
6 · The paper itself

Abstract

introductionA mandated reduction in the nicotine content of cigarettes would likely improve public health. Prior research has shown that assignment to very low nicotine content (VLNC) cigarettes reduces the reinforcement value of cigarettes. However, no studies have evaluated changes in reinforcement for smoking after experience with VLNC cigarettes in a marketplace where noncombusted nicotine products are available. AIMS AND

methodsAdult participants who smoke cigarettes (n = 438) were randomized 1:1 to VLNC or normal nicotine content cigarettes for 12 weeks. Participants purchased products using points valued at $1 from an experimental tobacco marketplace that contained study cigarettes and noncombusted nicotine products. At the 12-week visit, participants completed hypothetical purchase tasks for each product. Demand parameters were calculated, including intensity (consumption when product is free), breakpoint (price when consumption is reduced to zero), Pmax (price that produces maximum daily spending), Omax (maximum amount spent in a single day), and α (rate of change in consumption across the demand curve).

resultsAssignment to VLNC cigarettes reduced demand for study cigarettes across all parameters, and reduced demand for usual brand cigarettes for intensity and breakpoint, but not other parameters. Assignment to VLNC cigarettes increased Omax for e-cigarettes, but not other demand parameters. There were no significant differences in demand parameters for other products.

conclusionsA mandated reduction in cigarette nicotine content is likely to reduce the reinforcement value of cigarettes in a marketplace where noncombusted products are available, which may drive reductions in the prevalence of smoking and shift people who smoke toward noncombusted products. IMPLICATIONS: This is the first study to show that assignment to VLNC cigarettes along with access to noncombusted nicotine products reduces reinforcement value for both low nicotine and normal nicotine cigarettes, and may increase the reinforcement value of e-cigarettes. These results suggest that a mandated reduction in nicotine will decrease the prevalence of smoking and may increase the use of other noncombusted products.

Indexed as

Cigarette SmokingNicotineReinforcement, PsychologyTobacco ProductsAdultElectronic Nicotine Delivery SystemsFemaleHumansMaleMiddle AgedNicotine

Identifiers

PMID40613327
PMCPMC13010486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.